Holdings
Rosalind Advisors, Inc.
As of Sep 30, 2026, Rosalind Advisors, Inc. reported 31 positions worth US$295M. Largest: Delcath Systems, Inc., Verastem, Inc. and Fennec Pharmaceuticals Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Delcath Systems, Inc. | 3.3M | US$52.7M | no change | Sep 30, 2026 |
| Verastem, Inc. | 4.24M | US$34.1M | +250K | Sep 30, 2026 |
| Fennec Pharmaceuticals Inc. | 3.19M | US$34M | no change | Sep 30, 2026 |
| Xeris Biopharma Holdings, Inc. | 2.58M | US$24.7M | −326K | Sep 30, 2026 |
| Cybin, Inc. | 1.39M | US$17.1M | −569K | Sep 30, 2026 |
| Savara, Inc. | 3.18M | US$16.4M | no change | Sep 30, 2026 |
| Replimune Group, Inc. | 1M | US$13.2M | new | Sep 30, 2026 |
| Vor Biopharma Inc. | 609K | US$11.6M | −39,401 | Sep 30, 2026 |
| X4 Pharmaceuticals, Inc. | 3.21M | US$9.32M | no change | Sep 30, 2026 |
| Aquestive Therapeutics, Inc. | 2M | US$9.26M | +1.75M | Sep 30, 2026 |